Tweets

#ACR24: What Exactly do JAKs and TYKs Do?
Let me start by confessing something embarrassing: the immune system is just too complex for me to understand. I suspect the onslaught of new drugs with new mechanisms at ACR 2024 may have left many of you feeling similarly.… https://t.co/HkhZJBxDdO https://t.co/xYeSpHS2dD
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

Addressing CV Risk in RA: Are we doing enough?
The increased risk of cardiovascular disease in patients with rheumatoid arthritis has long been known (1). #ACR24
https://t.co/dajYuK8rpd https://t.co/2Ds3OZEjUX
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

Apremilast Benefits and Risks in PsA
Dr. Akhil Sood discusses abstracts 1466, 2583, 0598 and 2640 discussing the use of apremilast in PsA, presented at #ACR24.
https://t.co/SSEeR9Xt9B https://t.co/cUeSUQoRsO
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

#ACR24 BEST Abstracts from Day 2
Here’s a collection of some of the best abstracts presented on day 2 of ACR 2024 as selected by the RheumNow faculty.
https://t.co/9qiPhemEPl https://t.co/uGQEiCcfah
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

#ACR24 - Day 2 Report
Plenary sessions began the day, followed by thousands on the abstract floor. Here are a few of my favorite presentations from day 2 at ACR 2024.
https://t.co/TEWW0mDyl8 https://t.co/mZuqayonPN
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

RheumNow’s expanded coverage of the #ACR24 annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

Shedding Weight and Pain: The Promise of Anti-Obesity Medications in RA
For years, rheumatologists have championed weight loss as a cornerstone of care for patients with rheumatoid arthritis (RA) and obesity. RA is an independent risk factor for cardiovascular disease (CVD), a… https://t.co/iozo0FQFzj https://t.co/93e4nZMHJo
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

RheumNow Day 2 Recap: #ACR24 Highlights
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.… https://t.co/F3rZzOTiSJ https://t.co/t3wROMBe7D
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

RA: One JAK to Rule Them All? Dr. Brian Jaros reports on abstract 1362, presented at #ACR24. https://t.co/QChMyma3Y2 https://t.co/qq3BqpT2Gh
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

Transplant-free Survival Predictors in Idiopathic Inflammatory Myopathies-ILD
Dr. Gaby Martinez discusses abstract 0333, Predictors of Transplant-Free Survival in Idiopathic Inflammatory Myopathies- associated Interstitial Lung Disease, presented at #ACR24.… https://t.co/3TSZ6PvZsD https://t.co/DLdzzfXhhp
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis
Dr. Antoni Chan interviews Dr. Catherine Bakewell on the Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis, at #ACR24.
https://t.co/iCwNsuo7xz
@synovialjoints https://t.co/Tjx3CE27TK
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago

PsA Potpourri
Dr. Arthur Kavanaugh reviewed highlights on adult and pediatric sessions on uveitis, as well as interesting abstracts, at #ACR24
https://t.co/jsCMKHBFMk https://t.co/roZOZT3Mqd
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 months 3 weeks ago